Spark Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.23 M
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Spark Pharmachem
Spark Pharmachem Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 October 2006 and has a history of 18 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Aarti Life Science Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.23 M, as per Ministry of Corporate Affairs (MCA) records.
Harit Shah, Rashesh Gogri, and Adhish Patil serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2006PTC165136
- Company No.
165136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Spark Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harit Shah  | Director | 01-Jan-2011 | Current |
| Rashesh Gogri | Director | 01-Jan-2011 | Current |
| Adhish Patil | Director | 01-Jan-2011 | Current |
Financial Performance of Spark Pharmachem.
Spark Pharmachem Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Spark Pharmachem?
In 2017, Spark Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Salco Extrusions Private LimitedAdhish Patil is a mutual person
Aarti Industries LtdRashesh Gogri is a mutual person
Aarti Drugs LimitedHarit Shah and Rashesh Gogri are mutual person
Aarti Pharmalabs LimitedRashesh Gogri is a mutual person
Pinnacle Life Science Private LimitedHarit Shah and Adhish Patil are mutual person
Harshit Ventures Limited Liability Partn ErshipHarit Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spark Pharmachem?
Unlock and access historical data on people associated with Spark Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spark Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spark Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
